News

Bionure has launched today a crowdfunding campaign through the Spanish platform of Capital Cell (capitalcel.es) with the objective of raising €1.3M that will be used to finance the preparation of the phase 2 study of its neuroprotectant BN201....

Bionure is expanding its Scientific Advisory Board with the appointment of Dr. Amit Bar-Or, Director of the Center for Neuroinflammation and Experimental Therapeutics and Chief of the Multiple Sclerosis Center at the University of Pennsylvania Perelman School of Medicine (Philadelphia, USA)....